慢性心力衰竭患者80例临床分析

目的对慢性心力衰竭（CHF）患者的治疗及预后进行分析。方法选择CHF患者80例,随机分为两组,对照组40例,常规抗心衰治疗（强心、利尿、扩血管和血管紧张素转换酶抑制剂ACEI或血管紧张素Ⅱ受体拮抗剂）;观察组40例,在常规抗心衰治疗基础上,加用卡维地洛,观察4周,随访l8个月。治疗前后对比心功能、血压、心率、左室收缩末内径（LVESD）、左室射血分数（LVEF）的变化。结果在改善心脏结构和心功能,减少住院次数和心率,观察组优于对照组,差异均有统计学意义（P〈0.05）。结论β受体阻滞剂治疗CHF,能更好地改善心功能,减少CHF患者临床事件的发生,是一种安全、有效的方法。

Clinical Analysis of 80 Patients with Chronic Heart Failure

Objective Analysis 05 the treatment and prognosis Chronic heart failure （CHF）. Methods Total 80 cases of patients with CHF were randomly divided into two groups, control group 40 cases, conventional treatment of anti - heart failure （cardiac, diuretic, vasodilative and ACEI angiotensin - converting enzyme inhibitors or angiotensin Ⅱ receptor antagonist; 40 cases of the observation group, in the conventional treatment based on anti -heart failure, carvedilol was added to observe the 4 week follow - up 18 months. Comparison of cardiac function before and after treatment, blood pressure, heart rate, left ventricular end systolic diameter （LVESD） , left ventricular ejection fraction （LVEF） changes. Results The improvement of cardiac structure and cardiac function, re- duce hospitalization frequency and heart rate, the observation group than the control group, isbe tter the differences were statistically significant （P 〈 0.05 ）. Conclusion .β - blocker in treatment of CHF, can better improve the cardiac function in patients with CHF to reduce the occurrence of clinical events, is a safe, effective method.